Cipla Partners with Qilu for US Pembrolizumab Biosimilar
MM Desk
5 September, 2026
Invagen Pharmaceuticals Inc, a wholly owned subsidiary of Cipla Limited, has entered into a strategic
Invagen Pharmaceuticals Inc, a wholly owned subsidiary of Cipla Limited, has entered into a strategic
Cipla Limited and Sino Biopharmaceutical Limited (SBP Group) have entered into an exclusive licensing and
Cipla Limited has announced its unaudited consolidated financial results for the quarter ended June 30,
Cipla Limited announced strong financial performance for the financial year ended March 31, 2026, with
Cipla Limited and its wholly owned subsidiary Cipla USA Inc have received final approval from
Cipla Ltd has announced that its UK subsidiary will acquire the stake of a local
Cipla Ltd, announced on Friday (June 21) that its manufacturing facility in Goa, India, underwent
Mumbai-based pharmaceutical giant Cipla announced on Wednesday that it has received final approval from the
Cipla, a leading pharmaceutical company, announced today its decision to further invest up to Rs
Cipla promoters have sold 2.53% of their shares in the company to create liquidity for
© 2026 All Right Reserved Machine Maker
